Skip to main content
AAN.com

Abstract

Background and Objectives

Irregular sleep may increase the risk of cardiometabolic conditions, but its association with incident dementia is unclear. The aim of this study was to assess the association between sleep regularity, that is, the day-to-day consistency in sleep-wake patterns and the risk of incident dementia and related brain MRI endophenotypes.

Methods

We used Cox proportional hazard models to investigate the relationships between sleep regularity and incident dementia in 88,094 UK Biobank participants. The sleep regularity index (SRI) was calculated as the probability of being in the same state (asleep/awake) at any 2 time points 24 hours apart, averaged over 7 days of accelerometry.

Results

The mean age of the sample was 62 years (SD = 8), 56% were women, and the median SRI was 60 (SD = 10). There were 480 cases of incident dementia over a median 7.2 years of follow-up. Following adjustments for demographic, clinical, and genetic confounders (APOE ε4), there was a nonlinear association between the SRI and dementia hazard (p [global test of spline term] < 0.001) with hazard ratios (HRs) following a U-shape pattern. HRs, relative to the median SRI, were 1.53 (95% CI 1.24–1.89) for participants with SRI at the 5th percentile (SRI = 41) and 1.16 (95% CI 0.89–1.50) for those with SRI at the 95th percentile (SRI = 71). In a subset with brain MRI (n = 15,263), gray matter and hippocampal volume tended to be lowest at the extremes of the SRI.

Discussion

Sleep regularity displayed a U-shaped association with risk of incident dementia. Irregular sleep may represent a novel dementia risk factor.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (supplementary_data1.pdf)

References

1.
Sabia S, Fayosse A, Dumurgier J, et al. Association of sleep duration in middle and old age with incidence of dementia. Nat Commun. 2021;12(1):2289.
2.
Yuan S, Ma W, Yang R, et al. Sleep duration, genetic susceptibility, and Alzheimer's disease: a longitudinal UK Biobank-based study. BMC Geriatr. 2022;22(1):638.
3.
Huang SY, Li YZ, Zhang YR, et al. Sleep, physical activity, sedentary behavior, and risk of incident dementia: a prospective cohort study of 431,924 UK Biobank participants. Mol Psychiatry. 2022;27(10):4343-4354.
4.
Diem SJ, Blackwell TL, Stone KL, et al. Measures of sleep-wake patterns and risk of mild cognitive impairment or dementia in older women. Am J Geriatr Psychiatry. 2016;24(3):248-258.
5.
Yaffe K, Laffan AM, Harrison SL, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA. 2011;306(6):613-619.
6.
International-Agency-for-Research-on-Cancer. Painting, firefighting, and shiftwork. IARC Monogr Eval Carcinog Risks Hum. 2010;98:804.
7.
Phillips AJ, Clerx WM, O'Brien CS, et al. Irregular sleep/wake patterns are associated with poorer academic performance and delayed circadian and sleep/wake timing. Sci Rep. 2017;7(1):3216.
8.
Czeisler CA. Duration, timing and quality of sleep are each vital for health, performance and safety. Sleep Health. 2015;1(1):5-8.
9.
Lunsford-Avery JR, Engelhard MM, Navar AM, Kollins SH. Validation of the sleep regularity index in older adults and associations with cardiometabolic risk. Sci Rep. 2018;8(1):14158.
10.
Fritz J, Phillips AJK, Hunt L, et al. Cross-sectional and prospective associations between sleep regularity and metabolic health in the Hispanic community Health Study/Study of Latinos. Sleep. 2021;44(4):zsaa218.
11.
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672-2713.
12.
Fischer D, Klerman EB, Phillips AJ. Measuring sleep regularity: theoretical properties and practical usage of existing metrics. Sleep. 2021;44(10):zsab103.
13.
Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026-1034.
14.
Doherty A, Jackson D, Hammerla N, et al. Large scale population assessment of physical activity using wrist worn accelerometers: the UK biobank study. PLoS One. 2017;12(2):e0169649.
15.
Migueles JH, Rowlands AV, Huber F, Sabia S, van Hees VT. GGIR: a research community–driven open source R package for generating physical activity and sleep outcomes from multi-day raw accelerometer data. J Meas Phys Behav. 2019;2(3):188-196.
16.
Van Hees VT, Sabia S, Anderson KN, et al. A novel, open access method to assess sleep duration using a wrist-worn accelerometer. PLoS One. 2015;10(11):e0142533.
17.
van Hees VT, Sabia S, Jones SE, et al. Estimating sleep parameters using an accelerometer without sleep diary. Sci Rep. 2018;8(1):12975.
18.
UK Biobank Algorithmically-Defined Outcomes: Version 2.0. Accessed November 1, 2022. biobank.ndph.ox.ac.uk/showcase/showcase/docs/alg_outcome_main.pdf.
19.
Wilkinson T, Schnier C, Bush K, et al. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol. 2019;34(6):557-565.
20.
Alfaro-Almagro F, Jenkinson M, Bangerter NK, et al. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank. Neuroimage. 2018;166:400-424.
21.
Smith SM, Alfaro-Almagro F, Miller KL. UK Biobank Brain Imaging Documentation. Wellcome Centre for Integrative Neuroimaging (WIN-FMRIB), Oxford University on behalf of UK Biobank; 2020.
22.
Harrell FE Jr, Harrell MFE Jr. Package ‘hmisc’. CRAN2018. 2019;2019:235-236.
23.
Singer JD, Willett JB, eds. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. Oxford University Press; 2003.
24.
Floud S, Balkwill A, Sweetland S, et al. Cognitive and social activities and long-term dementia risk: the prospective UK Million Women Study. Lancet Public Health. 2021;6(2):e116-e123.
25.
Smith SM, Alfaro-Almagro F, Miller KL. UK Biobank Brain Imaging Documentation: Version 1.8. Accessed November 1, 2022. biobank.ctsu.ox.ac.uk/crystal/crystal/docs/brain_mri.pdf.
26.
Huang T, Redline S. Cross-sectional and prospective associations of actigraphy-assessed sleep regularity with metabolic abnormalities: the multi-ethnic study of atherosclerosis. Diab Care. 2019;42(8):1422-1429.
27.
Huang W-C, Chang S-H, Hsueh M-C, Liao Y. Relationship of sleep regularity with device-based sedentary behavior time and physical activity time in working adults. Sleep Health. 2023;9(1):86-92.
28.
Zuraikat FM, Makarem N, Redline S, Aggarwal B, Jelic S, St-Onge MP. Sleep regularity and cardiometabolic heath: is variability in sleep patterns a risk factor for excess adiposity and glycemic dysregulation? Curr Diab Rep. 2020;20(8):38.
29.
Posner AB, Tranah GJ, Blackwell T, et al. Predicting incident dementia and mild cognitive impairment in older women with nonparametric analysis of circadian activity rhythms in the Study of Osteoporotic Fractures. Sleep. 2021;44(10):zsab119.
30.
Tranah GJ, Blackwell T, Stone KL, et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol. 2011;70(5):722-732.
31.
Li P, Gao L, Gaba A, et al. Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adults. Lancet Healthy Longev. 2020;1(3):e96-e105.
32.
Ma Y, Liang L, Zheng F, Shi L, Zhong B, Xie W. Association between sleep duration and cognitive decline. JAMA Netw Open. 2020;3(9):e2013573.
33.
Westwood AJ, Beiser A, Jain N, et al. Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia. Neurology. 2017;88(12):1172-1179.
34.
Wild CJ, Nichols ES, Battista ME, Stojanoski B, Owen AM. Dissociable effects of self-reported daily sleep duration on high-level cognitive abilities. Sleep. 2018;41(12):zsy182.
35.
Lloyd-Jones DM, Allen NB, Anderson CA, et al. Life's Essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18-e43.
36.
Killick R, Stranks L, Hoyos CM. Sleep deficiency and cardiometabolic disease. Clin Chest Med. 2022;43(2):319-336.
37.
Zhu B, Wang Y, Yuan J, et al. Associations between sleep variability and cardiometabolic health: a systematic review. Sleep Med Rev. 2022;66:101688.
38.
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446.
39.
Lane CA, Barnes J, Nicholas JM, et al. Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study. Lancet Neurol. 2019;18(10):942-952.
40.
Jennings J, Mendelson D, Muldoon M, et al. Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure. J Hum Hypertens. 2012;26(5):295-305.
41.
Smith JC, Nielson KA, Woodard JL, et al. Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease. Front Aging Neurosci. 2014;6:61.
42.
Erickson KI, Leckie RL, Weinstein AM. Physical activity, fitness, and gray matter volume. Neurobiol Aging. 2014;35(suppl 2):S20-S28.
43.
Rabin JS, Klein H, Kirn DR, et al. Associations of physical activity and β-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA Neurol. 2019;76(10):1203-1210.
44.
Rabin JS, Schultz AP, Hedden T, et al. Interactive associations of vascular risk and β-amyloid burden with cognitive decline in clinically normal elderly individuals: findings from the Harvard Aging Brain Study. JAMA Neurol. 2018;75(9):1124-1131.
45.
Morin CM, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005-2015.
Letters to the Editor
31 January 2024
Author Response: Association of the Sleep Regularity Index With Incident Dementia and Brain Volume
Stephanie R. Yiallourou, PhD | School of Psychological Sciences, Monash University, Melbourne Australia
Lachlan Cribb, MEPi, PhD | School of Psychological Sciences, Monash University, Melbourne Australia
Andrée-Ann Baril, PhD | Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada
Matthew P. Pase, PhD | School of Psychological Sciences, Monash University, Melbourne Australia and Harvard T.H. Chan School of Public Health, Harvard University, MA

We thank Dr. Kawada for commenting on our study where we identified a U-shaped relationship between sleep regularity and dementia risk; dementia risk was highest in persons with the most irregular sleep.1 We agree that sleep is highly complex, with different sleep metrics reflecting different aspects of sleep quality. Our two papers published in this issue highlight this point.1,2 In this study,1  sleep regularity was associated with brain volume and dementia and these associations were independent of sleep duration and WASO,  with these models presented in our paper.

We did not exclude any dementia subtypes from our analysis. We studied all-cause dementia, which included dementia cases of several etiologies. We chose not to examine dementia subtypes separately given clinical diagnosis lacks precision and, most often, dementia is caused by multiple contributing pathologies. Further, when using UK Biobank healthcare datasets to identify dementia cases, the positive predictive values are much lower for dementia subtypes than all-cause dementia.3

As the reader suggests, there are many dementia risk factors and several could confound sleep-dementia associations. One strength of our paper was the robust consideration of confounding informed by a Directed Acyclic Graph (DAG). In total, our analyses adjusted for 23 covariates representing demographics, health/clinical, genetic, and social variables. Despite these comprehensive models, we cannot rule out residual confounding. Some of the factors suggested by the reader (e.g., immunity, metabolism) may not necessarily confound the sleep and dementia association, but perhaps serve as mediators, which we agree deserves further exploration.

We agree that the association between sleep and dementia could be bi-directional and this is something we have discussed here and elsewhere.1, 2, 4 Our comprehensive analysis represents an important step in understanding the relationship between irregular sleep and dementia with replication and extension in other cohorts needed.

  1. Yiallourou SR, Cribb L, Cavuoto MG, et al. Association of the Sleep Regularity Index With Incident Dementia and Brain Volume. Neurology. 2024;102(5):e208029.
  2. Baril AA, Kojis DJ, Himali JJ, et al. Association of Sleep Duration and Change Over Time With Imaging Biomarkers of Cerebrovascular, Amyloid, Tau, and Neurodegenerative Pathology. Neurology. 2024;102(6):e207807.
  3. Wilkinson T, Schnier C, Bush K, et al. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions, and mortality data. Eur J Epidemiol. 2019;34(6):557-565
  4. Himali JJ, Baril AA, Cavuoto MG, et al. Association Between Slow-Wave Sleep Loss and Incident Dementia. JAMA Neurol. 2023;80(10):1326-1333.

Author disclosures are available upon request([email protected]).

31 January 2024
Reader Response: Association of the Sleep Regularity Index With Incident Dementia and Brain Volume
Tomoyuki Kawada | Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan

Yiallourou et al. reported the effect of irregular sleep on the risk of dementia.1 The sleep regularity index (SRI) was calculated using an accelerometer, and adjusted hazard ratios (95% confidence intervals) of participants with SRI at the fifth and 95th percentiles against the median SRI for incident dementia were 1.53 (1.24–1.89) and 1.16 (0.89–1.50), respectively. Although SRI showed a U-shaped association with the risk of incident dementia, participants with regular sleep presented no significant association with incident dementia.

The same study group evaluated the association of sleep duration and its gradual change with amyloid, tau, neurodegeneration, and vascular neuroimaging markers of Alzheimer’s disease,2 and longer sleep duration was only associated with neurodegeneration and vascular neuroimaging markers. The authors observed an insignificant trend association of SRI with subsequent change in gray matter and hippocampal volumes. All-cause dementia was a clinical outcome,1 and types of dementia are excluded in the analysis. SRI and sleep duration present different characteristics in sleep, and both indicators might not directly present sleep quality. Some sleep indicators should be simultaneously used for the analysis to understand their relationship with dementia.

Sleep is an important lifestyle factor for maintaining good physical/mental health, and there may be a bidirectional association between sleep and dementia.3 Age-related factors, such as immunity and metabolism, sex differences, comorbidities, and some medications are closely related to the risk of dementia. Yiallourou et al. handled APOE ε4 as a genetic confounder, which is a key factor for the analysis. Overall, a comprehensive analysis is needed to understand the effect of irregular sleep on dementia.4,5

  1. Yiallourou SR, Cribb L, Cavuoto MG, et al. Association of the Sleep Regularity Index With Incident Dementia and Brain Volume. Neurology. 2024;102(2) :e208029.
  2. Baril AA, Kojis DJ, Himali JJ, et al. Association of Sleep Duration and Change Over Time With Imaging Biomarkers of Cerebrovascular, Amyloid, Tau, and Neurodegenerative Pathology. 2024;102(1):e207807.
  3. Thomas J, Ooms S, Verbeek M, et al. Sleep-Cognition Hypothesis In maritime Pilots, what is the effect of long-term work-related poor sleep on cognition and amyloid accumulation in healthy middle-aged maritime pilots: methodology of a case-control study. BMJ Open. 2019;9(6):e026992.
  4. Runk A, Lehrer HM, Butters MA, et al. Retired night shift workers exhibit poorer neurocognitive function compared to retired day workers. Sleep. 2023;46(11):zsad098.
  5. Meyer N, Harvey AG, Lockley SW, et al. Circadian rhythms and disorders of the timing of sleep. Lancet. 2022;400(10357):1061-1078.

Author disclosures are available upon request([email protected]).

Information & Authors

Information

Published In

Neurology®
Volume 102Number 2January 23, 2024
PubMed: 38165323

Publication History

Received: April 10, 2023
Accepted: October 13, 2023
Published online: December 13, 2023
Published in print: January 23, 2024

Permissions

Request permissions for this article.

Disclosure

The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.

Study Funding

M.P. Pase is supported by a National Health and Medical Research Council of Australia (GTN2009264, GTN1158384), National Institute on Aging (R01 AG062531), and Alzheimer's Association (2018-AARG-591358). M.G. Cavuoto and M.P. Pase are supported by a Dementia Australia Research Foundation award (Lucas' Papaw Remedies Project Grant). A.-A. Baril is funded by the Banting Fellowship Program (#454104). S.R. Yiallourou receives funding from the Alzheimer's Association (AARG-NTF-22-971405).

Authors

Affiliations & Disclosures

Stephanie R. Yiallourou, PhD* https://orcid.org/0000-0002-2433-6372
From the Turner Institute for Brain and Mental Health (S.R.Y., L.C., M.G.C., E.R., J.N., M.G., M.P.P.), School of Psychological Science, Monash University; National Ageing Research Institute (M.G.C.), Melbourne, Australia; Douglas Mental Health University Institute (A.-A.B.), McGill University, Montreal, Quebec, Canada; and Harvard T.H. Chan School of Public Health (M.P.P.), Harvard University, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Foundation - Alzheimer's Association (AARG-NTF-22-971405): Research grant, 2023-2025
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Turner Institute for Brain and Mental Health (S.R.Y., L.C., M.G.C., E.R., J.N., M.G., M.P.P.), School of Psychological Science, Monash University; National Ageing Research Institute (M.G.C.), Melbourne, Australia; Douglas Mental Health University Institute (A.-A.B.), McGill University, Montreal, Quebec, Canada; and Harvard T.H. Chan School of Public Health (M.P.P.), Harvard University, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
Direct compensation for contribution to data safety monitoring board - Genesis Trial - SVG Pharma
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Turner Institute for Brain and Mental Health (S.R.Y., L.C., M.G.C., E.R., J.N., M.G., M.P.P.), School of Psychological Science, Monash University; National Ageing Research Institute (M.G.C.), Melbourne, Australia; Douglas Mental Health University Institute (A.-A.B.), McGill University, Montreal, Quebec, Canada; and Harvard T.H. Chan School of Public Health (M.P.P.), Harvard University, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Received funding for travel - Dementia Centre for Research Collaboration Travel Scholarship (2019); Australasian Sleep Association Conference Student Travel Award (2016)
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Foundation - Dementia Australia Research Foundation (Lucas' Papaw Remedies Project Grant): Project Grant
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Turner Institute for Brain and Mental Health (S.R.Y., L.C., M.G.C., E.R., J.N., M.G., M.P.P.), School of Psychological Science, Monash University; National Ageing Research Institute (M.G.C.), Melbourne, Australia; Douglas Mental Health University Institute (A.-A.B.), McGill University, Montreal, Quebec, Canada; and Harvard T.H. Chan School of Public Health (M.P.P.), Harvard University, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Turner Institute for Brain and Mental Health (S.R.Y., L.C., M.G.C., E.R., J.N., M.G., M.P.P.), School of Psychological Science, Monash University; National Ageing Research Institute (M.G.C.), Melbourne, Australia; Douglas Mental Health University Institute (A.-A.B.), McGill University, Montreal, Quebec, Canada; and Harvard T.H. Chan School of Public Health (M.P.P.), Harvard University, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Governmental entities - RTP - FULL TIME STIPEND WITH FEE OFFSET: PhD Research Scholarship
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Turner Institute for Brain and Mental Health (S.R.Y., L.C., M.G.C., E.R., J.N., M.G., M.P.P.), School of Psychological Science, Monash University; National Ageing Research Institute (M.G.C.), Melbourne, Australia; Douglas Mental Health University Institute (A.-A.B.), McGill University, Montreal, Quebec, Canada; and Harvard T.H. Chan School of Public Health (M.P.P.), Harvard University, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Governmental - Australian Government Research Training Program Scholarship: Phd Stipend
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Turner Institute for Brain and Mental Health (S.R.Y., L.C., M.G.C., E.R., J.N., M.G., M.P.P.), School of Psychological Science, Monash University; National Ageing Research Institute (M.G.C.), Melbourne, Australia; Douglas Mental Health University Institute (A.-A.B.), McGill University, Montreal, Quebec, Canada; and Harvard T.H. Chan School of Public Health (M.P.P.), Harvard University, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Governmental granting agency - Canadian Institutes of Health Research: Banting Fellowship
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Foundation - Alzheimer Society of Canada: Outside of the work
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Turner Institute for Brain and Mental Health (S.R.Y., L.C., M.G.C., E.R., J.N., M.G., M.P.P.), School of Psychological Science, Monash University; National Ageing Research Institute (M.G.C.), Melbourne, Australia; Douglas Mental Health University Institute (A.-A.B.), McGill University, Montreal, Quebec, Canada; and Harvard T.H. Chan School of Public Health (M.P.P.), Harvard University, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Government - National Health and Medical Research Council (GTN2009264 ): Fellowship that pays my salary
Government - NIA ( AG062531): R01 grant on sleep and dementia
Government - National Health and Medical Research Council (GTN1158384): Project grant on sleep and dementia
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Foundation - Alzheimer Drug Discovery Foundation (GDAPB-202010-2020940 ): Project grant
Foundation - Alzheimer Association (AARG-591358 ): Project grant
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Pase [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Linda A. Hershey, MD, PhD, FAAN.
*
These authors contributed equally to this work as first authors.
These authors contributed equally to this work as joint senior authors.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Wearables in Chronomedicine and Interpretation of Circadian Health, Diagnostics, 15, 3, (327), (2025).https://doi.org/10.3390/diagnostics15030327
    Crossref
  2. Dose-response associations of device-measured sleep regularity and duration with incident dementia in 82391 UK adults, BMC Public Health, 25, 1, (2025).https://doi.org/10.1186/s12889-025-21649-z
    Crossref
  3. Sleep Timing, Sleep Timing Regularity, and Cognitive Performance in Women Entering Late Adulthood: The Study of Women's Health Across the Nation (SWAN), SLEEP, (2025).https://doi.org/10.1093/sleep/zsaf041
    Crossref
  4. Actualités de 2024 sur les troubles neurologiques du sommeil, Médecine du Sommeil, 22, 1, (12-15), (2025).https://doi.org/10.1016/j.msom.2025.01.219
    Crossref
  5. The Past and Future of Sleep Medicine, Sleep Medicine Clinics, 20, 1, (1-17), (2025).https://doi.org/10.1016/j.jsmc.2024.10.012
    Crossref
  6. Author Response: Association of the Sleep Regularity Index With Incident Dementia and Brain Volume, Neurology, 103, 2, (2024)./doi/10.1212/WNL.0000000000209339
    Abstract
  7. Reader Response: Association of the Sleep Regularity Index With Incident Dementia and Brain Volume, Neurology, 103, 2, (2024)./doi/10.1212/WNL.0000000000209333
    Abstract
  8. Next generation brain health: transforming global research and public health to promote prevention of dementia and reduce its risk in young adult populations, The Lancet Healthy Longevity, 5, 12, (100665), (2024).https://doi.org/10.1016/j.lanhl.2024.100665
    Crossref
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Short Form

Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share